Evidence map›Paper›PMID 40155705›Full record

ReviewNature protocols2025

Tutorial: guidelines for quality filtering of whole-exome and whole-genome sequencing data for population-scale association analyses.

Julia M Sealock, Franjo Ivankovic, Calwing Liao, Siwei Chen, Claire Churchhouse, Konrad J Karczewski, Daniel P Howrigan, Benjamin M Neale

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Exome sequencing directly implicates 68 genes in inflammatory bowel disease.medRxiv : the preprint server for health sciences · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julia M SealockAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. jsealock@broadinstitute.org.ORCID 0000-0002-9346-3498
Franjo IvankovicAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Calwing LiaoAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Siwei ChenAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Claire ChurchhouseAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0003-3140-6452
Konrad J KarczewskiAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0003-2878-4671
Daniel P HowriganAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Benjamin M NealeAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0003-1513-6077

Funding

1/4 Powering Genetic Discovery for Severe Mental Illness in Latin American and African AncestriesU01MH125047 · NIMH · BROAD INSTITUTE, INC. · PI MARTIN, ALICIA, NEALE, BENJAMIN MICHAEL · 2020 to 2024
$11.5M
Statistical methods for studies of rare variantsR01MH101244 · NIMH · HARVARD MEDICAL SCHOOL · PI Benjamin Michael Neale, ALKES L PRICE · 2013 to 2026
$9.4M
Statistical methods to localize disease heritability and identify biological mechanismsR37MH107649 · NIMH · BROAD INSTITUTE, INC. · PI Benjamin Michael Neale · 2019 to 2026
$7.0M
Novo Nordisk NNF21SA0072102Novo Nordisk Fonden (Novo Nordisk Foundation) NNF21SA0072102U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH101244U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R37MH107649U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) U01MH125047
6 · The paper itself

Abstract

Genetic sequencing technologies are powerful tools for identifying rare variants and genes associated with Mendelian and complex traits; indeed, whole-exome and whole-genome sequencing are increasingly popular methods for population-scale genetic studies. However, careful quality control steps should be taken to ensure study accuracy and reproducibility, and sequencing data require extensive quality filtering to delineate true variants from technical artifacts. Although processing standards are harmonized across pipelines to call variants from sequencing reads, there currently exists no standardized pipeline for conducting quality filtering on variant-level datasets for the purpose of population-scale association analysis. In this Tutorial, we discuss key quality control parameters, provide guidelines for conducting quality filtering of samples and variants, and compare commonly used software programs for quality control of samples, variants and genotypes from sequencing data. As sequencing data continue to gain popularity in genetic research, establishing standardized quality control practices is crucial to ensure consistent, reliable and reproducible results across studies.

Indexed as

ExomeExome SequencingGenome-Wide Association StudyWhole Genome SequencingGuidelines as TopicHigh-Throughput Nucleotide SequencingHumansQuality ControlSoftware

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.